|
gptkbp:instanceOf
|
gptkb:drug
recombinant hormone
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:ATCCode
|
gptkb:G03GA08
|
|
gptkbp:CASNumber
|
14310-51-1
|
|
gptkbp:contraindication
|
primary ovarian failure
ovarian cyst
adrenal dysfunction
uncontrolled thyroid disorder
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
choriogonadotropin alfa
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:macromoleculeType
|
gptkb:protein
|
|
gptkbp:manufacturer
|
gptkb:EMD_Serono
gptkb:Merck_Serono
|
|
gptkbp:marketedAs
|
gptkb:Ovidrel
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:producedBy
|
recombinant DNA technology
|
|
gptkbp:promotion
|
ovulation
luteinization
|
|
gptkbp:PubChem_CID
|
DB00011
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
abdominal pain
headache
injection site reaction
ovarian hyperstimulation syndrome
|
|
gptkbp:SIM
|
gptkb:human_chorionic_gonadotropin
|
|
gptkbp:target
|
gptkb:LHCG_receptor
|
|
gptkbp:UNII
|
P6DC1P0I2Z
|
|
gptkbp:usedFor
|
assisted reproductive technology
ovulation induction
|
|
gptkbp:bfsParent
|
gptkb:Ovidrel
|
|
gptkbp:bfsLayer
|
6
|